Autres langues Jenscare Scientific Co., Ltd.

Actions

9877

CNE100005KC9

Temps Différé Hong Kong S.E. Autres places de cotation 05:00:31 20/05/2024			Varia. 5j.	Varia. 1 janv.
4,97 ^HKD	+2,47 %		+10,44 %	-77,61 %

25/04	L'application LuX-Valve de Jenscare Scientific n'est pas approuvée par la NMPA, le prix de l'action chute de 11%.	MT
27/03	Jenscare Scientific Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%	25/04
Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Jenscare Scientific's Mitral Valve Device Completes Enrollment for Confirmatory Clinical Trials	25/03
Jenscare Scientific Co., Ltd. Announces Completion of the Enrollment of JensClip for Confirmatory Clinical Trial and One-Month Follow-Up	25/03
Jenscare Scientific Secures HKEX Nod for H Share Circulation	19/03
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation in Brazil	28/02
Jenscare Scientific’s CEO, CFO Boost Stake in Firm	26/01
Jenscare Scientific Unit Concludes 1st Clinical Implantation of PFO Occluder System	03/01
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation of Omniseal	03/01
Jenscare Scientific to Buy Back Shares	29/12
Jenscare Scientific Shareholders Approve of Sale of 22.48% Interest in Congenital Heart Disease Device Maker	22/12
Jenscare Scientific to Divest 22.5% Stake in Medical Device Maker	29/11
Jenscare Releases Results of Confirmatory Trial for Tricuspid Valve Replacement in London Meet	28/11
Jenscare Scientific Co., Ltd. Announces One-Year Results of the Confirmatory Clinical Trial of the LuX-Valve Transcatheter Tricuspid Valve Replacement System	28/11
Jenscare Scientific Enrolls First Patient for Atrial Appendage Occluder System Trial	13/11
Jenscare Presents Results of Tricuspid Valve Replacement System at US Conference	31/10/23
Jenscare Scientific Co., Ltd. Announces Lux-Valve Plus Travel II Results Released At the 2023 TCT in the U.S	31/10/23
Jenscare Shares Surge 16% After China Grants Priority Approval for Aortic Heart Valve System	30/10/23
Jenscare Scientific Co., Ltd. Announces Registration Application of Ken-Valve, the Transcatheter Prosthetic Aortic Heart Valve System Successfully Enters the Priority Approval Process	30/10/23
Jenscare Scientific Applies Valve Replacement System Under Fee-for-Service Scheme in Asia-Pacific; Shares Tumble 9%	20/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Jenscare Scientific Co., Ltd.

Actions

9877

CNE100005KC9

Autres langues

Filtres